Affordable Access

Publisher Website

Evolución en el tratamiento de los angiofibromas nasofaríngeos juveniles

Acta Otorrinolaringológica Española
Publication Date
DOI: 10.1016/j.otorri.2011.02.002
  • Angiofibroma Juvenil
  • Tumor Nasosinusal
  • Abordaje Quirúrgico
  • Cirugía Endoscópica Nasosinusal
  • Embolización
  • Juvenile Angiofibroma
  • Sinonasal Tumours
  • Surgical Approach
  • Sinonasal Endoscopic Surgery
  • Embolisation


Abstract Introduction Juvenile nasopharyngeal angiofibroma (JNA) is a rare benign tumour in adolescent males. It may be associated with a significant morbidity because of its anatomical location and its locally destructive growth pattern. Severe haemorrhage constitutes a high risk in JNA and its surgical management could be complex. Material and method We retrospectively analysed the clinical data from 43 patients with JNA surgically treated in our Department from 1993 until 2010. Mean postoperative follow-up time was 85 months. Results Analysis was performed on 42 males and one female. Mean patient age was 16 years old. The most common presenting symptoms were unilateral epistaxis (56%) and nasal obstruction (56%). Using the Fisch staging scale, tumours were classified as stage I in 2 patients, stage II in 9, stage III-a in 13, stage III-b in 13 and stage IV-a in 6. Preoperative selective embolisation was performed on 32 patients (74%). Thirty-three patients (77%) underwent an open surgical approach and 10 (23%) were treated by endoscopic approach. Complete resection of the lesion was achieved in 35 patients (81%) and tumour recurrence was observed in 2 (5%). All lesions treated via transnasal endoscopic approach were stage I and stage II lesions. Conclusion Surgery is the treatment of choice for JNA. An endoscopic approach is feasible for early-stage lesions (Fisch I and II) and conservative external approaches are still useful in advanced stages (Fisch III and IV). The open approaches proved helpful with respect to exposure, safety, cosmetic outcome and low morbidity. Preoperative embolisation, if possible, is mandatory.

There are no comments yet on this publication. Be the first to share your thoughts.